The role of plant lectins in cancer treatment

New Approaches in the Treatment of Cancer

Volumn , Issue , 2011, Pages 71-90

  Ferriz Martinez, Roberto A ^a   Torres Arteaga, Iovanna C ^a   Blanco Labra, Alejandro ^b   Garcia Gasca, Teresa ^a  

^a UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^b DEPARTAMENTO DE INGENIERÍA GENÉTICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895296601     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (102)

1. Lotan, R; Raz, A. Lectins in cancer cells. Ann. N. Y. Acad. Sci. 1988. 551(1): 385-396.
2. Wang, HX; Liu, WK; Ng, TB; Ooi, VEC; Chang, ST. The immunomodulatory and antitumor activities of lectins from the mushroom Tricholomamongolicum. Immunopharmacology. 1996. (31):205-211.
3. Sharon, N; Lis, H. Lectins as Cell Recognition Molecules. Science. 1989. 246:227-234.
4. Barondes, SH. Lectins: Their Multiple Endogenous Cellular Functions. Annual Review of Biochemistry. 1981. 50:207-231
5. Peumans, WJ; Van Damme, EJM. Lectins as plant defense proteins. Plant Physiol. 1995. 109:347-352.
6. Van Damme, EJM; Peumans, WJ; Barre, A; Rougé, P. Plant Lectins: A Composite of Several Distinct Families of Structurally and Evolutionary Related Proteins with Diverse Biological Roles. Critical Reviews in Plant Sciences. 1998. 17(6):575-692.
7. Castillo-Villanueva, A; Abdullaev, F. Lectinas vegetales y sus efectos en el cáncer. Revista de Investigación Clínica. 2005. 57(1):55-64.
8. González de Mejía, E; Prisecaru, VI. Lectins as bioactive plant proteins: a potential in cancer treatment. Critical Reviews in Food Science and Nutrition. 2005. 45:425-445
9. Konska, G; Wójtowicz, U; Pituch-Noworolska, A. Possible application of lectins in diagnostics and therapy. Part I. Diagnostic application Przegl Lek. 2008. 65(4):189-94
10. Hakomori, S. Tumor Malignancy Defined by Aberrant Glycosylation and Sphingo(glyco)lipid Metabolism. Cancer Research. 1996. 56:5309-5318
11. Gorelik, E; Galili, U; Raz, A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer and Metastasis Reviews. 2001. 20:245-277
12. Hakomori, S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res. 1985. 45:2405-2414
13. Nagata, Y. Function and structure of fungal lectins. Chem. Biol. 2000. 38:368-373
14. o Edition. Cold Spring Harbor, NY. USA. 1999. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=glyco.chapter.1520
15. o Edition. Cold Spring Harbor, NY. USA. 2009 http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=glyco
16. Hernández, P; Perez, E; Martínez, L; Ortiz, B; Martínez, G. Las Lectinas Vegetales como Modelo de Estudio de las Interacciones Proteína-Carbohidrato. REB 2005. 24(1):21-27.
17. Nishimura, H; Nishimura, M; Oda, R; Yamanaka, K; Matsubara, T; Ozaki, Y; Sekiya, K; Hamada, T; Kato, Y. Lectins induce resistance to proteases and/or mechanical stimulus in all examided cells-including bone marrow mesenchymal stem cells-on various scaffolds. Exp. Cell Res. 2004. 295: 119-127.
18. Kuwahara, I; Ikebuchi, K; Hamada, H; Niitsu, Y; Miyazawa, K; Furukawa, K. Changes in N-glycosilation of human stromal cells by telomerase expression. Biochem Biophys Res Commun. 2002. 301: 293-297.
19. Frantz, M; Jung, ML; Ribereau-Gayon, G; Anton, R. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins. Arzneimittelforschung. 2000. 50(5):471-478
20. Verena, E; Plattner, M; Ratzinger, G; Gabor, F; Wirth, M. Targeted drug delivery: Binding and uptake of plant lectins using human 5637 bladder cancer cells. Croat Med J. 2008. 48(3):318-33
21. Korourian, S; Siege, E; Kieber-Emmons, T; Monzavi-Karbassi. Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer. 2008. 8:138.
22. Garbor F;Stangl M; Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J Control Release 1998; 55: 131-42
23. Gabor, F; Klausegger, U; Wirth, M. The Interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int J Pharm. 2001. 221(1-2):35-47.
24. Parslew, R; Jones, KT; Rhodes, JM; Sharpe, GR. The antiproliferative effect of lectin from the edible mushroom (Agarics bisporus) on human keratinocytes: preliminary studies on its use in psoriasis. Br J Dermatol. 1999. 140:56-60.
25. Litynska, A; Przybylo, M; Pochec, E; Hoja-Lukowicz, D; Ciolczyk, D; Laidler, P; Gil, D. Comparison of the lectin-binding pattern in different human melanoma cell lines. Melanoma Res. 2001. 11:205-12.
26. Ravinder, S; Subramanian, S; Rhodes, JM; Campbell, BJ. Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes. Glycobiology. 2006. 16(7): 594-601
27. Konno, A; Hoshino, Y; Terashima, S; Motoki, R; Kawaguchi, T. Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin. Exp. Metastasis. 2002. 19(1):61-70.
28. Ruiz Álvarez V; Hernández-Triana M. 2002. Aspectos bioquímicos de la fitohemaglutinina. Aplicaciones en terapéutica médica. Instituto de Nutrición e Higiene de los Alimentos, Laboratorio de Bioquímica y Fisiología, Ciudad de La Habana, Cuba. http://www.monografias.com/trabajos20/fitohemaglutinina/fitohemaglutinina.shtml
29. Pryme, IF; Bardocz, S. Anti-cancer therapy: Diversion of polyamines in the gut. Eur. J. Gastroenterol. Hepatol. 2001. 13(9):1041-1046.
30. Lyu, SY; Choi, SH; Park, WB. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p-53. Arch. Pharm. Res. 2002. 25(1): 93-101.
31. Jordinson, M; El-Hariry, I; Calnan, D; Calam, J; Pignatelli, M. Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells. Gut. 1999. 44:709-714.
32. Abdullaev, FI; Gonzalez de Mejia, E. Antitumor effect of plant lectins. Natural toxins. 1997. 5:157-63
33. Lin, JK; Tserng, KY; Chen, CC; Lin, LT; Tung, TC. Abrin and ricin: new anti-tumor substances. Nature. 1970. 227:292-3.
34. Dickers, KJ; Bradberry, SM; Rice, P; Griffiths, GD; Vale, JA. Abrin poisoning. Toxicol Rev. 2003. 22(3):137-42.
35. Shoham, J; Inbar, M; Sachs, L. Differential toxicity on normal and transformed cells in vitro and inhibition of tumor development in vivo by Concanavalin A. Nature. 1970. 227:1244-6.
36. Zhao, C; Sun, H; Tong, X; Qi, Y. An antitumor lectin from the edible mushroom Agrocybe aegerita. Biochem J. 2003. 374:321-7.
37. Kent, D; Sheridan, CM; Tomkinson, HA; White, SJ; Hiscott, P; Yu, L; Grierson, I. Edible mushroom (Agaricus bisporus) lectin inhibits human retinal pigment epithelial cell proliferation in vitro. Wound Repair Regen. 2003. 11(4):285-91.
38. Yu, LG; Fernig, DG; White, MRH; Spiller, DG; Appleton, P; Evans, RC; Grierson, I; Smith, JA; Davies, H; Gerasimenko, OV; Petersen, OH; Milton, JD; Rhodes, JM. Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks nuclear localization sequence-dependent nuclear protein import. J Biol Chem. 1999. 274:4890-4899.
39. Yu, LG; Andrews, N; Weldon, M; Gerasimenko, OV; Campbell, BJ; Singh, R; Grierson, I; Petersen, OH; Rhodes, JM. An N-terminal truncated form of Orp 150 is a cytoplasmic ligand for the anti-proliferative mushroom Agaricus bisporus lectin and is required for nuclear localization sequence-dependent nuclear protein import. J Biol Chem. 2002. 227:24538-24545
40. Moriwaki, S; Ohba, H; Nakamura, O; Sallay, I; Suzuki, M; Tsubouchi, H; Yamasaki, N; Itoh, K. Biological activities of the lectin, abrin-a, against human lymphocytes, and cultured leukemic cell lines. J Hematother Stem Cell Res. 2000. 9(1):47-53.
41. Ramnath, V; Kuttan, G; Kuttan, R. Antitumor effect of abrin on transplanted tumours in mice. Indian J Physiol Pharmacol. 2002. 46(1):69-77.
42. Kaur, N; Singh, K; Rup, PJ; Saxena, AK; Khan, RH; Ashraf, MT; Kamboj SS; Singh, J. A tuber lectin from Arisaema helleborifolium Schott with anti-insect activity against melon fruit Xy, Bactrocera cucurbitae (Coquillett) and anti-cancer effect on human cancer cell lines. Arch Biochem Biophys. 2006. 445:156-165
43. Kaur, A; Singh Kamboj, S; Singh, J; Saxena, AK; Dhuna, V. Isolation of a novel Nacetyl-D-lactosamine specific lectin from Alocasia cucullata (Schott.). Biotech Letters. 2005. 27:1815-1820
44. Dhuna, V; Bains, JS; Kamboj, SS; Singh, J; Kamboj, S; Saxena, AK. Purification and characterization of a lectin from Arisaema tortuosum Schott having in-vitro anticancer activity against human cancer cell lines. J Biochem Mol Biol. 38(5):526-32
45. Sasaki, T; Yamazaki, K; Yamori, T; Endo, T. Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin. Br J Cancer. 2002. 87:918-23.
46. Chen, YF; Boland, CR; Kraus, ER; Goldstein, IJ. The lectin Griffonia simplicifolia IA4 (GSI-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LSII74 and SW1116. Int J Cancer. 1994. 57:561-7.
47. Knibbs, RN; Mac-Callum, DK; Lillie, JH; Goldstein, IJ. Wild-type and cultured Ehrlich ascites tumor cells differ in tumorigenicity, lectin binding pattern and binding to basement membranes. Glycobiology. 1994. 4:419-28.
48. Kuttan, G; Menon, LG; Antony, S; Kuttan, R. Anticarcinogenic and antimetastatic activity of Iscador. Anticancer Drugs. 1997. 8(Suppl 1):S15-S16.
49. Maier, G; Fiebig, HH. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anti-Cancer Drugs. 2002. 13:373-9
50. Zarkovic, N; Vukovic, T; Loncaric, I; Miletic, M; Zarkovic, K; Borovic, S; Cipak, A; Sabolovic, S; Konitzer, M; Mang, S. An overview on anticancer activities of the Viscum album extract Isorel. Cancer Biother Radiopharm. 2001. 16(1):55-62.
51. Schaffrath, B; Mengs, U; Schwarz, T; Hilgers, RD; Beuth, J; Mockel, B; Lentzen, H; Gerstmayer, B. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice. Anticancer Res. 2001. 21(6A):3981-3987.
52. Yoon, TJ; Yoo, YC; Kang, TB; Baek, YJ; Huh, CS; Song, SK; Lee, KH; Azuma, I; Kim, JB. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. Int. J. Immunopharmacol. 1998. 20(4-5):163-172.
53. Yoon, TJ; Yoo, YC; Kang, TB; Song, SK; Lee, KB; Her, E; Song, KS; Kim, JB. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch Pharm Res. 2003. 26:861-7.
54. Koyama, Y; Katsuno, Y; Miyoshi, N; Hayakawa, S; Mita, T; Muto, H; Isemura, S; Aoyagi, Y; Isemura, M. Apoptosis Induction by Lectin Isolated from Mushroom Boletopsis leucomelas in U937 Cells. Biosci Biotechnol Biochem. 2002. 66(4):784-9.
55. González de Mejía, E; Rocha, N; Winter, HC; Goldstein, IJ. Differential effect of a lectin from mesquite (Prosopis juliflora) on HeLa and normal human keratinocyte cells. FASEB J. 2002. 15(4):C 128.
56. Mengs, U; Schwarz, T; Bulitta, M; Weber, K; Madaus, AG. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice. Anticancer Res. 2000, 20(5B):3565-3568.
57. Knöpfl-Sidler F, Viviani A, Rist L, Hensel A. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts. Pharmazie. 2005. 60(6):448-54.
58. Urech, K; Buessing, A; Thalmann, G; Schaefermeyer, H; Heusser, P. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. Anticancer Res. 2006. 26(4B):3049-55.
59. Bantel, H; Engels, IH; Voelter, W; Schulze-Osthoff, K; Wesselborg, S. Mistletoes lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res. 1999. 59:2083-90.
60. Pryme, IF; Bardocz, S; Pusztai, A; Ewen, SW. Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma. Histol Histopathol. 2002. 17:261-71.
61. Pryme, IF; Bardocz, S; Pusztai, A; Ewen, SW; Pfuller, U. A mistletoe lectin (ML-1)containing diet reduces the viability of a murine non-Hodgkin lymphoma tumor. Cancer Detect Prevent. 2004. 28:52-6.
62. Kim, MS; Lee, J; Lee, KM; Yang, SH; Choi, S; Chung, SY; Kim, TY; Jeong, WH; Park, R. Involvement of hydrogen peroxide in mistletoe lectin-II-induced apoptosis of myeloleukemic U937 cells. Life Sci. 2003. 73(10):1231-1243.
63. Bussing, A; Stein, GM; Pfuller, U; Schietzel, M. Differential binding of toxic lectins from Viscum album L., ML I and ML III, to human lymphocytes. Anticancer Res. 1999. 19(6B):5095-5099.
64. Liu, B; Xu, X; Cheng, Y; Huang, J; Liu, Y; Liu, Z; Min, M; Bian, H; Chen, J; Bao, J. Apoptosis-inducing effect and structural basis of Polygonatum cyrtonema lectin and chemical modification properties on its mannose-binding sites. BMB Reports. 2008. 369-65.
65. Bardocz, S; Grant, G; Duguid, TJ; Brown, DS; Pusztai, A; Pryme, IF. Intracellular levels of polyamines in Krebs II lymphosarcoma cells in mice fed phytohaemagglutinin-containing diets are coupled with altered tumour growth. Cancer Lett. 1997. 121(1):25-29.
66. Rabellotti, E; Sessa, A; Tunici, P; Bardocz, S; Grant, G; Pusztai, A; Perin, A. Oxidative degradation of polyamines in rat pancreatic hypertrophy. Biochim. Biophys Acta. 1998. 1406(3):321-326.
67. Pryme, IF; Pustai; Bardocz, S; Ewen, SW. A combination of dietary protein depletion and PHA-induced growth gut reduce the mass of murine non-Hodgkin lymphoma. Cancer Lett. 1999a. 139:145-52.
68. Pryme, IF; Bardocz, S; Pusztai, A; Ewen SW. The growth of an established murine non-Hodgkin lymphoma tumour is limited by switching to a phytohaemagglutinincontaining diet. Cancer Lett. 1999b. 146:87-91
69. Pryme, IF; Pusztai, AJ; Bardocz, SA. Diet containing the lectin phytohaemagglutinin (PHA) slows the proliferation of Krebs II cell tumours in mice. Cancer Lett. 1994. 76:133-7.
70. Wang, H; Ng, TB; Ooi, VE; Liu, WK. Effects of lectins with different carbohydrate-binding specificities on hepatoma, choriocarcinoma, melanoma and osteosarcoma cell lines. Int. J. Biochem. Cell. Biol. 2000. 32(3):365-372.
71. Fang, K. A toxin conjugate containing transforming growth factor-alpha and ricin A specifically inhibits growth of A431 human epidermoid cancer cells. Proc. Natl. Sci. Counc. Repub. China B. 1998. 22(2):76-82.
72. Stein, G; Henn, W; von Laue, H; Berg, P. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur. J. Med. Res. 1998. 3(4):194-202.
73. Elsässer-Beile, U; Ruhnau, T; Freudenberg, N; Wetterauer, U; Mengs, U. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Cancer. 2001. 91(5):998-1004.
74. Schumacher, U; Feldhaus, S; Mengs, U. Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice. Cancer Lett. 2000. 150(2):171-175.
75. Hostanska, K; Vuong, V; Rocha, S; Soengas, MS; Glanzmann, C; Saller, R; Bodis, S; Pruschy, M. Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. Br. J. Cancer. 2003. 88(11):1785-1792.
76. Mukhopadhyay, P; Gupta, JD; Sanyal, U; Das, S. Influence of dietary restriction and soybean supplementation on the growth of a murine lymphoma and host immune function. Cancer Lett. 1994. 78:151-7.
77. Lin, P; Ye, X; Ng, T. Purification of melibiose-binding lectins from two cultivars of Chinese black soybeans. Acta Biochim Biophys Sin. 2008. 40(12):1029-1038.
78. Singh Bains, J; Singh, J; Kamboj, SS; Nijjar, KK; Agrewala, JN; Kumar, V; Kumar, A; Saxena, AK. Mitogenic and anti-proliferative activity of a lectin from the tubers of Voodoo lily (Sauromatum venosum). Biochim Biophys Acta. 2005. 1723(1-3):163-74.
79. Castañeda-Cuevas A, Yllescas-Gasca L, López-Martínez J, Mendiola-Olaya E, Blanco-Labra A, Garcia-Gasca T. 2007. Efecto Antiproliferativo In Vitro de una Lectina De Frijol Tépari sobre Diferentes Tipos de Cáncer Humano [online]. 2007. RESPYN Special edition No. 7. Available from: http://www.respyn.uanl.mx/especiales/2007/ee07-2007/index.html.
80. Wang, HX; Ng, TB; Ooi, VE; Liu, WK; Chang, ST. Actions of lectins from the mushroom Tricholoma mongolicum on macrophages, splenocytes and life-span in sarcoma-bearing mice. Anticancer Res. 1997.17:419-24
81. Timoshenko, AV; Lan, Y; Gabius, HJ; Lala, PK. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer. 2001. 37(15):1910-1920.
82. Siegle, I; Fritz, P; McClellan, M; Gutzeit, S; Murdter, TE. Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells. Anticancer Res. 2001. 21(4A):2687-2691.
83. Lyu, SY; Park, WB; Choi, KH; Kim, WH. Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci Biotechnol Biochem. 2001:65: 534-41.
84. Park, WB; Lyu, SY; Kim, JH; Choi, SH; Chung, HK; Ann, SH; Hong, SY; Yoon, TJ; Choi, MJ. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biother Radiopharm. 2001. 16:439-47.
85. Lyu, SY; Choi, SH; Park, WB. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharm Res. 2002. 25(1):1-8.
86. Jordison, M; El-Hariry, I; Calnan, D; Calam, J; Pignatelli, M. Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells. Gut. 1999. 44:709-14.
87. Litvinov, SV; Velders, MP; Bakker, HA; Fleuren, GJ; Warnaar, SO. Ep-CAM: A human epithelial is a homophilic cell-cell adhesion molecule. J Cell Biol. 1994. 125:437-446.
88. Mikkat, U; Damm, I; Kirchhoff, F; Albrecht, E; Nebe, B; Jonas, L. Effects of lectins on CCK-8-stimulated enzyme secretion and differentiation of the rat pancreatic cell line AR42J. Pancreas. 2001. 23(4):368-374.
89. Schwarz, RE; Wojciechowicz, DC; Picon, AI; Schwarz, MA; Paty, PB. Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells. Br J Cancer. 1999. 80(11):1754-1762.
90. Ganguly, C; Das, S. Plant lectins as inhibitors of tumor growth and modulators of host immune response. Chemotherapy. 1994. 40:272-8.
91. Ohba, H; Bakalova, R; Murakib, M. Cytoagglutination and cytotoxicity of Wheat Germ Agglutinin isolectins against normal lymphocytes and cultured leukemic cell lines- relationship between structure and biological activity. Biochim Biophys Acta. 2003. 1619:144-150.
92. Valentiner, U; Fabian, S; Schumacher, U; Leathem, AJ. The influence of dietary lectins on the cell proliferation of human breast cancer cell lines in vitro. Anticancer Res. 2003. 23(2B):1197-206.
93. Watzl, B; Neudecker, C; Hansch, GM; Rechkemmer, G; Pool-Zobel, BL. Dietary wheat germ agglutinin modulates ovalbumin-induced immune responses in Brown Norway rats. Br J Nutr. 2001. 85(4):483-490.
94. Kiss, R; Camby, I; Duckworth, D; De-Decker, R; Salmon, I; Pasteels, JL; Danguy, A; Yeaton, P. In vitro influence of Phaseolus vulgaris, Griffonia simplicifolia, Concanavalin A, wheat germ and peanut agglutinins on HCT-15, LoVo and SW 837 human colorrectal cancer cell growth. Gut. 1997. 40:253-61.
95. Riaño-Sánchez R. Importancia y aplicaciones de las lectinas [online]. 1997. Available from: http://www.monografias.com/trabajos11/lecti/lecti.shtml
96. Friess, H; Beger, HG; Kunz, J; Funk, N; Schilling, M; Buchler, MW. Treatment of advanced pancreatic cancer with mistletoe: Results of a pilot trial. Anticancer Res. 1996. 16(2):915-920.
97. Steuer-Vogt, MK; Bonkowsky, V; Ambrosch, P; Scholz, M; Neiss, A; Strutz, J; Hennig, M; Lenarz, T; Arnold, W. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomised controlled clinical trial. Eur J Cancer. 2001. 37(1):23-31.
98. Lyu, SY; Park, SM; Choung, BY; Park, WB. Comparative study of Korean (Viscum album var. coloratum) and European mistletoes (Viscum album). Arch Pharm Res. 2000. 23:592-8.
99. Gomg, F; Ma, Y; MA, A; Yu, Q; Zhang, J; Nie, H; Chen, X; Shen, B; Li, N; Zhang, D. A Lectin from Chinese Mistletoe Increases δγ T Cell-mediated Cytotoxicity through Induction of Caspase-dependent Apoptosis. Acta Biochim Biophys Sinica. 2007. 39(6):445-452.
100. Rhodes, JM. Beans means lectins. Gut. 1999. 44:593-594.
101. Tareq, al-Ati. Plant lectins. PoisonousPlants [online]. 2001. Available from: http://www.ansci.cornell.edu/plants/toxicagents/lectins.html
102. Lajolo, F; Genovese, M. Nutricional significance of lectins and enzyme inhibitors from legumes. J Agric Food Chem. 2002. 50:6592-6598.